Metformin, an FDA approved first-line drug for the treatment of type 2 diabetes, has known beneficial effects on glucose metabolism. Evidence from animal models and in vitro studies suggest that…
Read More
News
A Trial for the Ages: The Metformin Study
New Research Seeks to Add More Healthy, Productive Years of Life – For Canines
Researchers at the University of Washington in Seattle Healthy Aging and Longevity Research Institute have embarked on a new research regimen to determine the effects of potential drugs on optimizing…
FDA Approves Metformin for New Cancer Trials
Some exciting research from the University of Montreal has found that the drug metformin, commonly prescribed for diabetes and polycystic ovary syndrome (PCOS), has the potential to reduce multiple cancers…
Public Education
“The Critical Need to Promote Research of Aging and Aging-related Diseases to Improve Health and Longevity of the Elderly Population” Aging and Disease, International Society on Aging and Disease (ISOAD),…
Policy Research
Areas of Policy Research and Development Key Priorities Connect our Fellows to the new $1.8 billion annual NIH fund for Cures currently under congressional approval through the 21st Century Act,…
